top of page
gradientForSurfBreak.png

Item List

PR Newswire
Strados Labs Receives FDA 510(k) Clearance for Home Use of its Smart Sensor Platform

Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and predictions of worsening respiratory diseases, today announced it has received FDA Class II 510(k) clearance for home use of its first product, RESP®, which make this its second FDA clearance in less than 18 months.

Recent Posts

Portfolio Company

Carlsmed.png

Access Pediatric Partners with Strados Labs to Provide Pediatric Pulmonology Pat ...

KTLA 5

General News

Carlsmed.png

All Health Care Problems are Data Problems ...

Medical Economics

General News

Carlsmed.png

Dr. Tshaka Cunningham Carves a Path for African Americans in Science ...

San Diego Voice and Viewpoint

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page